Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (16858)	5/19/2005 2:36:13 PM
From: zeta1961	Respond to of 52153

Oh boy, Genentech's future is doomed.. Niet!..whoever wrote that must be short! or wishes they bought in February..DNA is one of the savviest biotech companies on the street today.. small bio's, advocacy org's, oncologists, even Morgan Stanley family members who lost a colleague to brain cancer who created ABC2(squared) wants to be/is associated with them(to highlight a couple of TNTC(too numerous to count).. Filling the pipe?..ain't no gas shortage in their world.. Long DNA..I'm having ideologic issues with their big pharma-like behaviour..but least financially anxiety producing company in my 'folio.. all imo, Zeta